| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Neumora Therapeutics (NASDAQ:NMRA) through any online brokerage.
Other companies in Neumora Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Neumora Therapeutics has a consensus price target of $5.88.
The stock price for Neumora Therapeutics (NASDAQ: NMRA) is $0.46 last updated October 20, 2026 at 6:20 PM EDT.
There are no upcoming dividends for Neumora Therapeutics.
Neumora Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Neumora Therapeutics.
Neumora Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
